<div id="readability-page-1">Core Scientific, Inc. (NASDAQ:CORZ) is one of the 11 Best Performing IPOs in the Last 2 Years. Despite the decline in revenue and mixed analyst opinions, the company’s upside potential remains positive. Core Scientific, Inc. (NASDAQ:CORZ) announced revenue of $78.63 million for the quarter ended June 2025, a 44.3% year-over-year decline. It also fell back […]</div>

CORZ

<p>Core Scientific, Inc.（納斯達克代碼：CORZ）在 2025 年第二季度報告的收入為 7863 萬美元，同比下降 44.3%。儘管這一下降以及分析師的情緒不一，該公司仍被認為是過去兩年中表現最佳的 11 個首次公開募股之一，並對未來的增長保持積極展望</p>

儘管收入有所下降且分析師意見不一，Core Scientific 仍然保持積極的前景